Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Schiappoli

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Recenti Progressi in Medicina|June 8, 2002
[Alternative tests in the diagnosis of food allergies]Gianenrico Senna, Federica Gani, Gualtiero Leo, et al.
Expert Review of Clinical Immunology|October 9, 2013
Balancing efficacy against safety in sublingual immunotherapy with inhalant allergens: what is the best approach?Marco Caminati, Annarita Dama, Michele Schiappoli, et al.
Recenti Progressi in Medicina|August 12, 2003
[Asthma and aspirin]Michele Schiappoli, Federica Gani, Francesco Frati, et al.
Hand (New York, N.Y.)|June 16, 2026
Reliability of Tactile Sensitivity Measurement With Semmes-Weinstein's Monofilaments in Community-Dwelling AdultsFrancesco Ferrarello, Michele Schiappoli, Samuele Nebbiai, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 23, 2016
What lies beyond Asthma Control Test: Suggestions for clinical practiceMarco Caminati, Cristian Caimmi, Annarita Dama, et al.
Rheumatology (Oxford, England)|September 11, 2023
Successful switching from mepolizumab to dupilumab in a patient with EGPA in remission phase and persistent nasal polyposisMarco Caminati, Elena Scarpieri, Matteo Maule, et al.
European Annals of Allergy and Clinical Immunology|February 11, 2004
Nimesulide and meloxicam are a safe alternative drugs for patients intolerant to nonsteroidal anti-inflammatory drugsGian Enrico Senna, Giovanni Passalacqua, Annarita Dama, et al.
European Journal of Internal Medicine|November 19, 2019
Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case seriesMarco Caminati, Elisa Olivieri, Francesca Nalin, et al.
Expert Review of Respiratory Medicine|June 15, 2022
Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical managementMarco Caminati, Bianca Olivieri, Annarita Dama, et al.
Multidisciplinary Respiratory Medicine|February 7, 2022
Multidisciplinary management of type 2 inflammatory diseasesGianenrico Senna, Claudio Micheletto, Giorgio Piacentini, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Recenti Progressi in Medicina|June 8, 2002
[Alternative tests in the diagnosis of food allergies]Gianenrico Senna, Federica Gani, Gualtiero Leo, et al.
Expert Review of Clinical Immunology|October 9, 2013
Balancing efficacy against safety in sublingual immunotherapy with inhalant allergens: what is the best approach?Marco Caminati, Annarita Dama, Michele Schiappoli, et al.
Recenti Progressi in Medicina|August 12, 2003
[Asthma and aspirin]Michele Schiappoli, Federica Gani, Francesco Frati, et al.
Hand (New York, N.Y.)|June 16, 2026
Reliability of Tactile Sensitivity Measurement With Semmes-Weinstein's Monofilaments in Community-Dwelling AdultsFrancesco Ferrarello, Michele Schiappoli, Samuele Nebbiai, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 23, 2016
What lies beyond Asthma Control Test: Suggestions for clinical practiceMarco Caminati, Cristian Caimmi, Annarita Dama, et al.
Rheumatology (Oxford, England)|September 11, 2023
Successful switching from mepolizumab to dupilumab in a patient with EGPA in remission phase and persistent nasal polyposisMarco Caminati, Elena Scarpieri, Matteo Maule, et al.
European Annals of Allergy and Clinical Immunology|February 11, 2004
Nimesulide and meloxicam are a safe alternative drugs for patients intolerant to nonsteroidal anti-inflammatory drugsGian Enrico Senna, Giovanni Passalacqua, Annarita Dama, et al.
European Journal of Internal Medicine|November 19, 2019
Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case seriesMarco Caminati, Elisa Olivieri, Francesca Nalin, et al.
Expert Review of Respiratory Medicine|June 15, 2022
Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical managementMarco Caminati, Bianca Olivieri, Annarita Dama, et al.
Multidisciplinary Respiratory Medicine|February 7, 2022
Multidisciplinary management of type 2 inflammatory diseasesGianenrico Senna, Claudio Micheletto, Giorgio Piacentini, et al.
Pageof 3